StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Nutra Pharma's free cash flow for the twelve months ending Dec 31, 2025 was -$1.19M. For fiscal 2025 it was -$1.19M. The highest annual figure on record is -$169.68K in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.19M–
FY2022Dec 31, 2022-$820.43K–
FY2021Dec 31, 2021-$1.78M–
FY2020Dec 31, 2020-$883.99K–
FY2017Dec 31, 2017-$1.15M–
FY2016Dec 31, 2016-$1.36M–
FY2015Dec 31, 2015-$1.02M–
FY2014Dec 31, 2014-$169.68K–
FY2012Dec 31, 2012-$721.24K–
FY2011Dec 31, 2011-$1.89M–
FY2010Dec 31, 2010-$1.43M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$219.82K–
Q3 FY2025Sep 30, 2025-$250.77K–
Q2 FY2025Jun 30, 2025-$288.37K–
Q1 FY2025Mar 31, 2025-$431.06K–
Q4 FY2022Dec 31, 2022-$54.03K–
Q3 FY2022Sep 30, 2022-$165.34K–
Q2 FY2022Jun 30, 2022-$284.83K–
Q1 FY2022Mar 31, 2022-$316.23K–
Q4 FY2021Dec 31, 2021-$237.96K–
Q3 FY2021Sep 30, 2021-$417.52K–
Q2 FY2021Jun 30, 2021-$523.75K–
Q1 FY2021Mar 31, 2021-$604.28K–

More Nutra Pharma figures

See a number that looks wrong?